Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Feb 14th 2020, Silver Chartbook – Bullish tone but not low risk

Bullish tone but not low risk Silver has shown some relative weakness towards gold within the precious metal sector in recent days. Looking at the weekly chart we can see that the distribution zone near US$18.60 has successfully rejected silver prices a second time...
Korbinian Koller | February 18, 2020 |

Axsome Therapeutics Investors Awaken to Positive Outcome in Phase 2 Narcolepsy Trial

Axsome Therapeutics shares traded 14% higher today after the company reported that its narcolepsy drug candidate AXS-12 achieved its primary endpoint in the Phase 2 CONCERT Study. This morning before U.S. markets opened, clinical-stage biopharmaceutical company Axsom...
Streetwise Reports | December 4, 2019 |

PROFIT! A NEW Stockhouse Vodcast Series. Eps. 2

Get to know capital market moguls, mavens and management teams in a more relaxed setting. Episodes open with fun, rapid-fire questions, setting the tone for a more informal one-on-one session. You won’t want to miss our weekly releases featuring thought ...
Cindy Broad | January 24, 2020 |

Cashing in the Exploding Esports and Esports Betting Markets

Get to know capital market moguls, mavens and management teams in a more relaxed setting. Episodes open with fun, rapid-fire questions, setting the tone for a more informal one-on-one session. You won’t want to miss our weekly releases featuring thought ...
Cindy Broad | February 17, 2020 |

PROFIT! A NEW Stockhouse Vodcast Series. Eps. 6

Get to know capital market moguls, mavens and management teams in a more relaxed setting. Episodes open with fun, rapid-fire questions, setting the tone for a more informal one-on-one session. You won’t want to miss our weekly releases featuring thought...
Cindy Broad | January 31, 2020 |

Theralase is raising up to $5.3M to complete bladder cancer study

Theralase Technologies is announcing a brokered financing raise for up to C$5.3 million Proceeds of the financing will be used to further the Phase II Non-Muscle Invasive Bladder Cancer (NMIBC) clinical study Ruvidar is designed to destroy solid core tum...
Coreena Robertson | November 6, 2023 |

Neovasc Shares Climb 80% Upon FDA Premarket Approval Filing for Refractory Angina Device

Shares of specialty cardiovascular medical device company Neovasc Inc. opened more than 100% higher after the firm reported that it submitted a Premarket Approval application to the FDA for its Neovasc Reducer device for use in the treatment of refractory angina. This...
Streetwise Reports | January 3, 2020 |

MyoKardia Shares Get a Jolt from Positive Phase 3 HCM Clinical Trial Results

Shares of MyoKardia traded 60% higher, setting a new 52-week high price, after the company reported that it met all primary and secondary endpoints in the Phase 3 EXPLORER study of mavacamten in treatment of obstructive hypertrophic cardiomyopathy. Clinical-...
Streetwise Reports | May 12, 2020 |

PROFIT! A NEW Stockhouse Vodcast Series. Eps. 1

Get to know capital market moguls, mavens and management teams in a more relaxed setting. Episodes open with fun, rapid-fire questions, setting the tone for a more informal one-on-one session. You won’t want to miss our weekly releases featuring thought ...
Cindy Broad | January 24, 2020 |

PROFIT! A NEW Stockhouse Vodcast Series. Eps. 3

Get to know capital market moguls, mavens and management teams in a more relaxed setting. Episodes open with fun, rapid-fire questions, setting the tone for a more informal one-on-one session. You won’t want to miss our weekly releases featuring thought ...
Cindy Broad | January 27, 2020 |
1 2 3 4 5 6 7 8 9